Dyne Therapeutics Inc reports results for the quarter ended in December - Earnings Summary

Dyne Therapeutics

05/03/2024 23:30

* Dyne Therapeutics Inc  DYN.OQ  reported a quarterly
adjusted
loss of $1.09​​ per share for the quarter ended in December,
lower than the same quarter last year, when the company reported
EPS of -74 cents.  The mean expectation of nine analysts for the
quarter was for a loss of 92 cents per share. Wall Street
expected results to range from $-1.08 to -73 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Dyne Therapeutics Inc's reported EPS for the quarter was a
loss
of $1.09​.
    * The company reported a quarterly loss of $66.64 million.
    * Dyne Therapeutics Inc shares had risen by 108.3% this
quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 1.7%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 9 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
    * Wall Street's median 12-month price target for Dyne
Therapeutics
Inc is $35.50 

This summary was machine generated from LSEG data March 5 at
11:29 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2023      -0.92          -1.09          Missed
 Sep. 30 2023      -0.83          -0.99          Missed
 Jun. 30 2023      -0.81          -1.08          Missed
 Mar. 31 2023      -0.77          -0.78          Missed